C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation
In ovarian cancer, the mechanism of chemoresistance is a key question. Here, the authors demonstrate that C/EBPβ and DOT1L together increase methylation of H3K79, which upregulates expression of oncogenic genes and drives poor platinum response and poor survival in ovarian cancer.
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/c9b30596b94249a2a0f1f7ff2dd6da2e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|